Session Description: A new frontier in treating mental health conditions, psychedelic therapy has brought about lasting change for patients and people around the world. Dr. Michael Verbora, MBA MD will present the research-based evidence of the efficacy of psychedelic therapies, and outline the ongoing clinical work, using ketamine-assisted therapy to treat treatment-resistant mental health conditions with lasting success.
Learning Objectives:
After this activity participants should be able to
Describe the field of psychedelic medicine and the importance of a holistic model of care (as it pertains to psychedelic-assisted therapy)
Evaluate the early clinical evidence and Field Trip Health data on results of the new options in ketamine-assisted therapy
Assess and describe the key indications and contraindications to drug-assisted therapy